🗣Are you a #PhD student or #postdoc interested in learning more about #industry career options, both #bench and non-bench?
Join us with @MSKEducation -Office of Career and Professional Development- and @Stempeer15 on March 9 and 15th
https://t.co/HS3YbcD3GU
MedNess is committed to being a one-stop-shop for biopharma and biotech news. 📁Subscribe to get more like this weekly newsletter in your inbox: https://t.co/yBiwEYLdmZ
Check out Onco This Week (OTW) and more.
🔬 REGULATORY NE…https://t.co/S5PlTdT9Zt https://t.co/ZxVmqXDZCz
Follow MedNess newsletters for real-time data and the newest information on Biotech and Biopharma. Check out Onco This Week (OTW) and more.
📁Subscribe to get more like this weekly newsletter in your inbox: https://t.co/yBiwEYtCvr…https://t.co/5jipGZSFAi https://t.co/efpj4iM1n1
MedNess brings headlines and news roundup emails free forever. Check out our new incorporation of Neuroimmunology and Immunotherapies with Onco This Week (OTW).
📁Subscribe to get more like this weekly newsletter in your inbox: ht…https://t.co/gVHuDfum4Y https://t.co/5F4VyL3PqP
Check out the latest edition of MedNess newsletter. 📁Subscribe to get more like this weekly newsletter in your inbox: https://t.co/yBiwEYtCvr
Check out Onco This Week (OTW) and more.
💊 DRUG APPROVAL
📌 European Commission Amg…https://t.co/o1Y5Q4yuYl https://t.co/89GPV0r3lc
MedNess is a one-stop weekly news update for biotech and biopharma news.
Check out Onco This Week (OTW) and more.
📁Subscribe to get more like this weekly newsletter in your inbox: https://t.co/yBiwEYtCvr
🔬 REGULATORY NEWS
FDA…https://t.co/djCEL3K8o9 https://t.co/FPtRthVw5g
MedNess wishes all a very Happy and Sparkling New Year!!! The last year was a great success for us. We are excited to grow even more this year. Check out our first edition of 2022 on Onco This Week (OTW) and more.
📁Subscribe to g…https://t.co/JoO9X4tTLs https://t.co/tirOmMw4Gn
MedNess wishes all the members, followers, and subscribers a warm, wonderful, happy, and safe holiday❄️⛄️🎇🎆🎅🏽. During this break, check out Onco This Week (OTW) and more. Please Like and share to help spread the updates.
📁Sub…https://t.co/bv5ZQsXWz5 https://t.co/jXlGCcBKiP
#MedNess on weekly developments in biopharma and biotech industry. Check out Onco This Week (OTW) and more. Please Like and share to help spread the updates.
📁Subscribe to get more like this weekly newsletter in your inbox: https:…https://t.co/5KMb4zgPJc https://t.co/fCMZkmGTpR
MedNess newsletter is back after the #thanksgiving2021 Holidays. We are immensely grateful to our followers and subscribers. Thank you all for your support and love.
📁Subscribe to get more like this weekly newsletter in your inbo…https://t.co/5pDGyz84Qg https://t.co/0ye8j3TJ42
#MedNess Newsletter aims to provide not only the update of biopharma and biotech industry but also capture the pace and vastness of it. Check out Onco This Week (OTW) and more.
📁Subscribe to get more like this weekly newsletter in…https://t.co/oNOlUSkECh https://t.co/IaXQEF62Uh
#MedNess will help you to keep up with the pace and diversity of the Pharma industry. Check out Onco This Week (OTW) and more.
🔬 REGULATORY NEWS
📌 Amgen’s LUMYKRAS Receives '+'ve Opinion From @European Medicines Agency CHMP For Advanced NSCLC
📌 Gamid…https://t.co/CHjXp7EnYx